Taizhou, China

Xinzeng Wang

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Zhejiang Hisun Pharmaceutical Co., Ltd.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xinzeng Wang. Retrieved from https://idiyas.com/inventor/xinzeng-wang-mt1kvt8l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Xinzeng Wang in Pharmaceutical Development

Introduction

Xinzeng Wang is a notable inventor based in Taizhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new drug formulations. His work focuses on improving the quality and stability of medicinal products.

Latest Patents

Xinzeng Wang holds a patent for "Crystal forms of bedaquiline fumarate and preparation methods therefor." This patent includes the development of crystal forms I, II, and III of bedaquiline fumarate. These crystal forms are characterized by high purity, excellent physicochemical properties, and good stability. The preparation methods outlined in the patent can effectively enhance product quality and are suitable for the preparation and mass production of medicines.

Career Highlights

Wang is associated with Zhejiang Hisun Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical innovation. His work has contributed to advancements in drug formulation and production processes.

Collaborations

Xinzeng Wang has collaborated with notable colleagues, including Jinyi Xu and Liang Zhang, to further enhance the impact of his research and innovations.

Conclusion

Xinzeng Wang's contributions to pharmaceutical development through his innovative patent demonstrate his commitment to improving drug quality and production methods. His work continues to influence the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…